{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:26:26Z","timestamp":1759623986859,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.ejogrb.2010.07.038","type":"journal-article","created":{"date-parts":[[2010,8,22]],"date-time":"2010-08-22T04:49:54Z","timestamp":1282452594000},"page":"207-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical significance of pmTOR expression in endometrioid endometrial carcinoma"],"prefix":"10.1016","volume":"153","author":[{"given":"Chel Hun","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Rim","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoung-Gie","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duk-Soo","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2010.07.038_bib0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","article-title":"Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study","volume":"40","author":"Morrow","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2010.07.038_bib0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","article-title":"Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study","volume":"24","author":"Randall","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2010.07.038_bib0015","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2010.07.038_bib0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00001703-200202000-00010","article-title":"PTEN mutations and evolving concepts in endometrial neoplasia","volume":"14","author":"Latta","year":"2002","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2010.07.038_bib0025","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrc1974","article-title":"mTOR and cancer: insights into a complex relationship","volume":"6","author":"Sabatini","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejogrb.2010.07.038_bib0030","first-page":"295","article-title":"Inhibitors of mammalian target of rapamycin as novel antitumor agents: from bench to clinic","volume":"3","author":"Huang","year":"2002","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.ejogrb.2010.07.038_bib0035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ctrv.2006.10.007","article-title":"Systemic therapy in metastatic or recurrent endometrial cancer","volume":"33","author":"Pectasides","year":"2007","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ejogrb.2010.07.038_bib0040","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.critrevonc.2005.11.002","article-title":"Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: hormonal therapy, chemotherapy and molecularly targeted therapies","volume":"58","author":"Gadducci","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejogrb.2010.07.038_bib0045","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/jcp.2006.040170","article-title":"Validation of tissue microarray technology in endometrioid cancer of the endometrium","volume":"60","author":"Fons","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ejogrb.2010.07.038_bib0050","first-page":"1409","article-title":"Activation of mTOR in a subgroup of ovarian carcinomas: correlation with p-eIF-4E and prognosis","volume":"20","author":"Noske","year":"2008","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ejogrb.2010.07.038_bib0055","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00432-008-0529-5","article-title":"Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro","volume":"135","author":"Darb-Esfahani","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ejogrb.2010.07.038_bib0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ygyno.2009.10.040","article-title":"Expression of metabolically targeted biomarkers in endometrial carcinoma","volume":"116","author":"Wahl","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2010.07.038_bib0065","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.bjc.6602902","article-title":"mTOR signaling: implications for cancer and anticancer therapy","volume":"94","author":"Petroulakis","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejogrb.2010.07.038_bib0070","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1158\/1078-0432.CCR-07-0738","article-title":"Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinoma","volume":"13","author":"Herberger","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejogrb.2010.07.038_bib0075","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1158\/1078-0432.CCR-09-0099","article-title":"High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinoma","volume":"15","author":"Anagnostou","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejogrb.2010.07.038_bib0080","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1245\/ASO.2006.07.011","article-title":"Activated Akt and Erk expression and survival after surgery in pancreatic carcinoma","volume":"13","author":"Chadha","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejogrb.2010.07.038_bib0085","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.molmed.2005.06.007","article-title":"An expanding role for mTOR in cancer","volume":"11","author":"Guertin","year":"2005","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ejogrb.2010.07.038_bib0090","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1101\/gad.887201","article-title":"Regulation of translation initiation by FRAP\/mTOR","volume":"15","author":"Gingras","year":"2001","journal-title":"Genes Dev"},{"key":"10.1016\/j.ejogrb.2010.07.038_bib0095","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1126\/science.285.5436.2126","article-title":"Drosophila S6 kinase: a regulator of cell size","volume":"285","author":"Montagne","year":"1999","journal-title":"Science"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211510003726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211510003726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:23:57Z","timestamp":1759555437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211510003726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0301211510003726"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2010.07.038","relation":{},"ISSN":["0301-2115"],"issn-type":[{"type":"print","value":"0301-2115"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical significance of pmTOR expression in endometrioid endometrial carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2010.07.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}